-
+2 +1
Elton John and Prince Harry launch bid to 'smash' AIDS stigma
Elton John joined forces with Britain's Prince Harry to launch a $1.2 billion initiative on Tuesday to "break the cycle" of HIV transmission by targeting young men, among whom infections are on the rise. On the second day of a major international AIDS conference in Amsterdam, the two lent their mega-wattage star power to calls for action to end the lingering stigma around the virus and protect generations to come.
-
+16 +1
‘It’s sobering’: A once-exciting HIV cure strategy fails its test in people
When Science published a monkey study nearly 2 years ago that showed an anti-inflammatory antibody effectively cured monkeys intentionally infected with the simian form of the AIDS virus, the dramatic results turned many heads. But some skeptical researchers thought the data looked too good to be true and predicted the intervention wouldn’t work on HIV in humans. They were right.
-
+14 +1
HIV diagnoses fall to their lowest level in the UK since 2000
New HIV diagnoses in the UK have fallen to their lowest level since 2000, figures show. There was a 17% drop in the number of new diagnoses last year, declining from 5,280 in 2016 to 4,363 in 2017, Public Health England (PHE) said. Numbers have reduced by more than a quarter (28%) since 2015 and are at their lowest since 2000, when there were 3,989.
-
+13 +1
Powerful antibodies suppress HIV for months, could simplify treatment
Anti-HIV drugs have prevented millions of early deaths from AIDS, but infected people must take the pills every day, for life. Now, two studies in small numbers of people show for the first time that infusions of two powerful anti-HIV antibodies can completely suppress the virus for several months. If the results pan out in larger studies, they could simplify treatment for people who have difficulty taking daily medication, reduce the risk of drug resistance emergence, and even help cut HIV transmission rates.
-
+20 +1
China sees surge in HIV/Aids cases
China has announced a 14% jump in the number of its citizens who are living with HIV and Aids. More than 820,000 people are affected in the country, health officials say. About 40,000 new cases were reported in the second quarter of 2018 alone. The vast majority of new cases were transmitted through sex, marking a change from the past. Traditionally, HIV spread rapidly through some parts of China as a result of infected blood transfusions.
-
+19 +1
Spanish doctors 'eliminate' HIV from patient in stem cell transplant trial
SPANISH scientists believe they may have managed to eliminate HIV from a patient using stem cell transplant treatment. Scientists from the Institute for AIDS Research IrsiCaixa in Barcelona and the Gregorio Maranon Hospital in Madrid have managed to remove the virus from the blood and tissues of six patients using the treatment.
-
+31 +1
All Hail the Condom King
Bill Gates highlights the work of Mechai Viravaidya who has helped save millions of lives by promoting easier access to contraception.
-
+7 +1
First Human Clinical Trial of HIV Drug Gammora: a Step Closer to a Potential Cure
An Israeli biotech company specializing in HIV and cancer treatments has finally released the results of its first clinical trial of its HIV-drug Gammora and the news is bringing renewed hope to the many affected by this devastating retrovirus. The novel drug has been found to eliminate up to 99% of the HIV virus within four weeks of treatment.
-
+8 +1
Apple Has Raised $200 Million Through (PRODUCT)RED Sales to Fight AIDS
Apple, a longtime supporter of AIDS research through its (RED) partnership, today shared some details on the work (RED) is doing to put an end to AIDS in Africa with the money it raises for the Global Fund. Since its founding in 2006, (RED) has raised more than $600 million to support the Global Fund, $200 million of which has come from Apple.
-
+3 +1
Trump quietly shuts down HIV cure research to appease the religious right
Scientists are speaking out against a directive by the Trump administration that has shut down research into a cure for HIV. A scientist who was supposed to supply mice that have been modified with human fetal tissue for an HIV study emailed researchers that the Department of Health and Human Services (HHS) “has directed me to discontinue procuring fetal tissue.” “This effectively stops all of our research to discover a cure for HIV,” he wrote.
-
+9 +1
H.I.V. Is Reported Cured in a Second Patient, a Milestone in the Global AIDS Epidemic
Scientists have long tried to duplicate the procedure that led to the first long-term remission 12 years ago. With the so-called London patient, they seem to have succeeded.
-
+8 +1
Monthly HIV injection could free patients from gruelling drug regimen
Long-acting medicines have proved as effective as daily pills in preventing HIV from replicating, according to results from twin trials that enrolled more than 1,000 people in 16 countries. The drugs tested, cabotegravir and rilpivirine, are given once a month as an injection. They are the first of several long-acting antiretroviral HIV medicines in development, which researchers hope will tackle one of the toughest challenges in the fight against HIV: how to ensure that people consistently take the drugs that can prevent the virus from replicating in their cells. Skipped doses put people with HIV, and their sexual partners, at risk.
-
+10 +1
First Ever Living Donor Hiv-To-Hiv Kidney Transplant
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV. A multidisciplinary team from Johns Hopkins Medicine completed the living donor HIV-to-HIV kidney transplant on Mar. 25. The doctors say both the donor and the recipient are doing well. “This is the first time someone living with HIV has been allowed to donate a kidney, ever, in the world, and that’s huge,” says Dorry Segev, M.D., Ph.D., professor of surgery at the Johns Hopkins University School of Medicine.
-
+6 +1
End to Aids in sight as huge study finds drugs stop HIV transmission
An end to the Aids epidemic could be in sight after a landmark study found men whose HIV infection was fully suppressed by antiretroviral drugs had no chance of infecting their partner. The success of the medicine means that if everyone with HIV were fully treated, there would be no further infections.
-
+24 +1
Scientists Identify Factors That Make People Naturally Resistant to H.I.V.
Developing an H.I.V. vaccine has been a perplexing challenge that has mostly resulted in failure, but now scientists have identified key factors that allow some people to naturally suppress the H.I.V. virus—work that could lead to better vaccines to both treat and prevent the infection. Researchers believe they have identified crucial points on the virus's surface where the immune system can successfully attack H.I.V.
-
+16 +1
Gilead to donate HIV prevention drug to 200,000 patients
Gilead Sciences will give free Truvada pills to 200,000 uninsured people for the next 11 years to help prevent new HIV infections, the pharmaceutical company said Thursday. The announcement of the donation came just one day after the company said a generic version of the daily pill would be available in September 2020, a year earlier than expected.
-
+3 +1
Genetic Mutation that Prevents HIV Infection Tied to Earlier Death
Those with two copies of the delta32 allele in the CCR5 gene are 21 percent more likely to die by age 76, although it's not clear why.
-
+26 +1
Scientists Reveal Unexpected Outcome of China's Rogue Human Gene Editing Trial
In 2018, the Chinese scientist He Jiankui, Ph.D., altered the DNA of two human embryos, which were born as two healthy twin girls named Lulu and Nana. Against the violent ethical uproar in the medical community, He defended his experiment by claiming that the genetic changes he made were benign — they were meant to promote HIV resistance — but research published Monday in Nature Medicine has revealed that he may have spoken too soon.
-
+4 +1
For the First Time, Researchers Eliminate HIV From the Genomes of Living Animals
There’s no question that powerful anti-HIV medications can do a fairly good job of keeping the virus under control. Used properly, these anti-retroviral drugs (ARVs) can suppress HIV enough to keep it at levels so low they’re undetectable in the blood, which drastically lowers the chance of spreading the virus during sexual activity or transfusions. But ARVs can only do so much.
-
+6 +1
Trial of HIV prevention implant hailed as boost in fight against disease
An implant containing an HIV-prevention drug has been trialled in humans, in a step experts have hailed as an exciting development in curtailing infections. Pre-exposure prophylaxis, or PrEP, with antiretroviral drugs has become a hot topic in recent years, with the drugs shown to substantially reduce the risk of contracting HIV from an HIV-positive partner. PrEP pills are already available through the NHS in Scotland to high-risk individuals, while trials are under way in England.
Submit a link
Start a discussion